Back to results
US 2026/0069540 A1Published application
Gene delivery agents
AssigneeTIBA Biotech LLC
InventorsPoulami Talukder, Maria Varghese, Heliang Song, Nathan Ivanowsky
Life of this patent
Estimating the term…
Abstract
Nanoparticle compositions for delivery of nucleic acids to subjects including aminoalkyl branched lipid-like molecules as carriers, and therapeutic or immunogenic nucleic acid agents enclosed within the nanoparticle containing are described. Also provided are methods for treating or preventing diseases or conditions in a subject by administering the nanoparticle compositions that provide immune responses and synergistic therapeutic or preventive effects.
Claims26
A compound of Formula I:
- in which
- YA is H, C1-C4 alkyl, C2-C4 alkenyl, or C2-C4 alkynyl;
- ZA is C1-C30 amino, C1-C30 amido, C1-C30 carbonyl, C1-C30 carboxylate, diazolyl, or triazolyl, each of which is substituted with one or more of hydroxyl, C2-C20 carboxylate, hydroxyphenyl, C1-C10 phosphate, sugar, C1-C30 disulfanyl, ethylene glycol, or C4-C30 polyethylene glycol;
- ZB is
- each of LC or LD is CH2 or O;
- each of ZC and ZD, independently, is C1-C30 alkyl, C2-C30 alkenyl, or C2-C30 alkynyl;
- LK1 is C3-C8 alkylene or alkylene-heterocycloalkylene-alkylene;
- each of LK2, LK3, and LK4, independently, is a bond, C1-C8 alkylene, C2-C8 alkenylene, C2-C8 alkynylene, or alkylene-heterocycloalkylene-alkylene;
- and
- wherein the compound has 20 to 200 carbon atoms.
7 more elements
A compound selected from the group consisting of Compounds 47, 50, and 52-55.
Dependencies are inferred from the claim text.